Mononeuropathy following subcutaneous interferon-beta injection.
Capasso
M
M
Caulo
M
M
De Luca
G
G
Magarelli
N
N
Lugaresi
A
A
D000328:Adult; D005260:Female; D006225:Hand / Q000294:innervation / Q000503:physiopathology; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects; D007249:Inflammation / Q000139:chemically induced / Q000276:immunology / Q000503:physiopathology; D007279:Injections, Subcutaneous / Q000009:adverse effects; D016899:Interferon-beta / Q000009:adverse effects*; D008279:Magnetic Resonance Imaging; D008833:Microcirculation / Q000187:drug effects / Q000503:physiopathology; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy; D018908:Muscle Weakness / Q000139:chemically induced / Q000276:immunology / Q000503:physiopathology; D018482:Muscle, Skeletal / Q000294:innervation / Q000503:physiopathology; D009431:Neural Conduction / Q000187:drug effects / Q000276:immunology; D014459:Ulnar Nerve / Q000187:drug effects* / Q000293:injuries* / Q000473:pathology; D020424:Ulnar Neuropathies / Q000139:chemically induced* / Q000276:immunology / Q000503:physiopathology
D007155:Immunologic Factors; D016899:Interferon-beta